Does Rallies show 13F holders for SEM?

Yes. Rallies tracks hedge fund and 13F ownership data for SEM, including fund names, share counts, latest tracked quarter, and position changes when available.

Is SEM research on Rallies investment advice?

No. Rallies provides research, data, and educational context for SEM. It does not provide personalized investment advice.

SEM (SELECT MEDICAL HOLDINGS CORP) Stock Analysis - Hedge Fund Holdings

SELECT MEDICAL HOLDINGS CORP (SEM) is a publicly traded Healthcare sector company. As of May 21, 2026, SEM trades at $16.52 with a market cap of $2.04B and a P/E ratio of 14.28. SEM moved +0.27% today. Year to date, SEM is +9.04%; over the trailing twelve months it is +9.26%. Its 52-week range spans $11.65 to $40.98. Analyst consensus is neutral with an average price target of $16.50. Rallies surfaces SEM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns SEM stock?

Hedge funds tracked by Rallies that own SEM include Soros Fund, Bridgewater Associates, and Eisler Capital. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for SELECT MEDICAL HOLDINGS CORP.

SEM Key Metrics

Key financial metrics for SEM
Metric	Value
Price	$16.52
Market Cap	$2.04B
P/E Ratio	14.28
EPS	$1.16
Dividend Yield	0.06%
52-Week High	$40.98
52-Week Low	$11.65
Volume	0
Avg Volume	0
Revenue (TTM)	$5.45B
Net Income	$214.53M
Gross Margin	0.00%

Top Hedge Funds Holding SEM

Soros Fund holds 1.83M shares of SEM, changed +0.00% as of Mar 31, 2026.
Bridgewater Associates holds 65.17K shares of SEM, changed +58.37% as of Dec 31, 2025.
Eisler Capital holds 23.48K shares of SEM, changed -3.45% as of Jun 30, 2024.

Latest SEM News

Select Medical Agrees $16.50 Share Merger, Q1 Revenue Climbs 5% to $1.42B — Apr 30, 2026
Select Medical HSR Antitrust Waiting Period Expires Ahead of Mid-2026 Merger — Apr 28, 2026
Select Medical Faces Probe Over $16.50 Cash-Per-Share Buyout Deal — Apr 14, 2026
Shareholder Suit Targets Select Medical $16.50 Cash Deal With Executive-Led Consortium — Mar 10, 2026
Select Medical Sale Faces Investigation Over $16.50 Executive-Led Consortium Deal — Mar 6, 2026

Recent SEM Insider Trades

Khanuja Parvinderjit S. bought 21.00K (~$315.42K) on May 5, 2025.
CHERNOW DAVID S sold 225.00K (~$4.05M) on Apr 28, 2025.
Breighner Robert G. JR sold 4.99K (~$99.53K) on Dec 4, 2024.

SEM Analyst Consensus

4 analysts cover SEM: 0 strong buy, 0 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $16.50.

Common questions about SEM

Who owns SEM stock?: Hedge funds tracked by Rallies that own SEM include Soros Fund, Bridgewater Associates, and Eisler Capital. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for SELECT MEDICAL HOLDINGS CORP.
Does Rallies show 13F holders for SEM?: Yes. Rallies tracks hedge fund and 13F ownership data for SEM, including fund names, share counts, latest tracked quarter, and position changes when available.
Is SEM research on Rallies investment advice?: No. Rallies provides research, data, and educational context for SEM. It does not provide personalized investment advice.